• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FGF15 激活 Hippo 信号通路以抑制胆汁酸代谢和肝脏肿瘤发生。

FGF15 Activates Hippo Signaling to Suppress Bile Acid Metabolism and Liver Tumorigenesis.

机构信息

State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian 361102, China; Cancer Research Center of Xiamen University, Xiamen, Fujian 361102, China.

State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian 361102, China.

出版信息

Dev Cell. 2019 Feb 25;48(4):460-474.e9. doi: 10.1016/j.devcel.2018.12.021. Epub 2019 Feb 7.

DOI:10.1016/j.devcel.2018.12.021
PMID:30745141
Abstract

The external factors that modulate Hippo signaling remain elusive. Here, we report that FGF15 activates Hippo signaling to suppress bile acid metabolism, liver overgrowth, and tumorigenesis. FGF15 is induced by FXR in ileal enterocytes in response to increased amounts of intestinal bile. We found that circulating enterohepatic FGF15 stimulates hepatic receptor FGFR4 to recruit and phosphorylate NF2, which relieves the inhibitory effect of Raf on the Hippo kinases Mst1/2, thereby switching FGFR4's role from pro-oncogenic to anti-tumor signaling. The activated Mst1/2 subsequently phosphorylates and stabilizes SHP to downregulate the key bile acid-synthesis enzyme Cyp7a1 expression, thereby limiting bile acid synthesis. In contrast, Mst1/2 deficiency impairs bile acid metabolism and remarkably increases Cyp7a1 expression and bile acid production. Importantly, pharmacological depletion of intestinal bile abrogates Mst1/2-mutant-driven liver overgrowth and oncogenesis. Therefore, FGF15-Hippo signaling along the gut-liver axis acts as a sensor of bile acid availability to restrain liver size and tumorigenesis.

摘要

调节 Hippo 信号的外部因素仍然难以捉摸。在这里,我们报告 FGF15 通过激活 Hippo 信号来抑制胆汁酸代谢、肝脏过度生长和肿瘤发生。FGF15 是 FXR 在回肠肠细胞中响应增加的肠道胆汁而诱导的。我们发现循环肠肝 FGF15 刺激肝受体 FGFR4 招募和磷酸化 NF2,从而解除 Raf 对 Hippo 激酶 Mst1/2 的抑制作用,从而将 FGFR4 的作用从促癌转变为抗肿瘤信号。激活的 Mst1/2 随后磷酸化并稳定 SHP 以下调关键的胆汁酸合成酶 Cyp7a1 的表达,从而限制胆汁酸的合成。相比之下,Mst1/2 缺陷会损害胆汁酸代谢,并显著增加 Cyp7a1 的表达和胆汁酸的产生。重要的是,肠道胆汁的药理学耗竭可消除 Mst1/2 突变驱动的肝脏过度生长和肿瘤发生。因此,沿肠道-肝脏轴的 FGF15-Hippo 信号作为胆汁酸可用性的传感器,可限制肝脏大小和肿瘤发生。

相似文献

1
FGF15 Activates Hippo Signaling to Suppress Bile Acid Metabolism and Liver Tumorigenesis.FGF15 激活 Hippo 信号通路以抑制胆汁酸代谢和肝脏肿瘤发生。
Dev Cell. 2019 Feb 25;48(4):460-474.e9. doi: 10.1016/j.devcel.2018.12.021. Epub 2019 Feb 7.
2
FGF15/FGFR4 integrates growth factor signaling with hepatic bile acid metabolism and insulin action.成纤维细胞生长因子15/成纤维细胞生长因子受体4将生长因子信号传导与肝脏胆汁酸代谢及胰岛素作用整合在一起。
J Biol Chem. 2009 Apr 24;284(17):11110-20. doi: 10.1074/jbc.M808747200. Epub 2009 Feb 23.
3
Alterations in Enterohepatic Fgf15 Signaling and Changes in Bile Acid Composition Depend on Localization of Murine Intestinal Inflammation.肠肝循环中Fgf15信号的改变及胆汁酸组成的变化取决于小鼠肠道炎症的部位。
Inflamm Bowel Dis. 2016 Oct;22(10):2382-9. doi: 10.1097/MIB.0000000000000879.
4
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis.成纤维细胞生长因子15作为一种肠肝信号,调节胆汁酸稳态。
Cell Metab. 2005 Oct;2(4):217-25. doi: 10.1016/j.cmet.2005.09.001.
5
Hepatic Autophagy Deficiency Remodels Gut Microbiota for Adaptive Protection via FGF15-FGFR4 Signaling.肝自噬缺陷通过 FGF15-FGFR4 信号重塑肠道微生物群以实现适应性保护。
Cell Mol Gastroenterol Hepatol. 2021;11(4):973-997. doi: 10.1016/j.jcmgh.2020.10.011. Epub 2020 Oct 23.
6
FXR-induced secretion of FGF15/19 inhibits CYP27 expression in cholangiocytes through p38 kinase pathway.FXR 诱导的 FGF15/19 分泌通过 p38 激酶通路抑制胆管细胞中 CYP27 的表达。
Pflugers Arch. 2014 May;466(5):1011-9. doi: 10.1007/s00424-013-1364-3. Epub 2013 Sep 26.
7
Bile acids, FGF15/19 and liver regeneration: From mechanisms to clinical applications.胆汁酸、FGF15/19 和肝再生:从机制到临床应用。
Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1326-1334. doi: 10.1016/j.bbadis.2017.06.025. Epub 2017 Jul 12.
8
FGF15 improves outcomes after brain dead donor liver transplantation with steatotic and non-steatotic grafts in rats.成纤维细胞生长因子 15 可改善脑死亡供肝移植大鼠肝内脂肪变性和非脂肪变性供肝的预后。
J Hepatol. 2020 Nov;73(5):1131-1143. doi: 10.1016/j.jhep.2020.05.007. Epub 2020 May 15.
9
Bile Acids as Hormones: The FXR-FGF15/19 Pathway.作为激素的胆汁酸:FXR-FGF15/19信号通路
Dig Dis. 2015;33(3):327-31. doi: 10.1159/000371670. Epub 2015 May 27.
10
The ileal FGF15/19 to hepatic FGFR4 axis regulates liver regeneration after partial hepatectomy in mice.回肠 FGF15/19 至肝 FGFR4 轴调节小鼠肝部分切除术后的肝再生。
J Physiol Biochem. 2018 May;74(2):247-260. doi: 10.1007/s13105-018-0610-8. Epub 2018 Feb 22.

引用本文的文献

1
FGF15/FGFR4 signaling suppresses M1 macrophage polarization and multi-organ inflammation in septic mice by inhibiting H3K18 lactylation-driven Irf7 expression through NF2-Hippo activation.成纤维细胞生长因子15/成纤维细胞生长因子受体4信号通路通过激活NF2-河马通路抑制H3K18乳酸化驱动的干扰素调节因子7表达,从而抑制脓毒症小鼠的M1巨噬细胞极化和多器官炎症。
Cell Death Dis. 2025 Aug 19;16(1):628. doi: 10.1038/s41419-025-07962-w.
2
Therapeutic Plasma Exchange: Current and Emerging Applications to Mitigate Cellular Signaling in Disease.治疗性血浆置换:减轻疾病中细胞信号传导的当前及新兴应用
Biomolecules. 2025 Jul 12;15(7):1000. doi: 10.3390/biom15071000.
3
Bile acid accumulation induced by miR-122 deficiency in liver parenchyma promotes cancer cell growth in hepatocellular carcinoma.
肝实质中miR-122缺乏诱导的胆汁酸积累促进肝细胞癌中癌细胞的生长。
Mol Ther Nucleic Acids. 2025 May 14;36(2):102560. doi: 10.1016/j.omtn.2025.102560. eCollection 2025 Jun 10.
4
The potential of 4-Methylumbelliferone to be repurposed for treating liver fibrosis.4-甲基伞形酮用于治疗肝纤维化的潜在用途。
bioRxiv. 2025 May 23:2025.05.19.654778. doi: 10.1101/2025.05.19.654778.
5
Intergenerational Enlargement of Human Organs as a Driver of Increased Cancer Risk?人类器官的代际增大是癌症风险增加的驱动因素?
Bioessays. 2025 Aug;47(8):e70024. doi: 10.1002/bies.70024. Epub 2025 Jun 4.
6
Harnessing the FGFR2/NF2/YAP signaling-dependent necroptosis to develop an FGFR2/IL-8 dual blockade therapeutic strategy.利用FGFR2/NF2/YAP信号依赖的坏死性凋亡来制定FGFR2/IL-8双重阻断治疗策略。
Nat Commun. 2025 May 3;16(1):4128. doi: 10.1038/s41467-025-59318-9.
7
Disrupting bile acid metabolism by suppressing Fxr causes hepatocellular carcinoma induced by YAP activation.通过抑制法尼醇X受体(Fxr)破坏胆汁酸代谢会导致由Yes相关蛋白(YAP)激活诱导的肝细胞癌。
Nat Commun. 2025 Apr 15;16(1):3583. doi: 10.1038/s41467-025-58809-z.
8
Farnesoid X Receptor Regulated Sepsis-Induced Abnormal Bile Acid Metabolism via the Fibroblast Growth Factor 15/Fibroblast Growth Factor Receptor 4 Pathway.法尼酯X受体通过成纤维细胞生长因子15/成纤维细胞生长因子受体4途径调节脓毒症诱导的异常胆汁酸代谢。
Immun Inflamm Dis. 2025 Apr;13(4):e70155. doi: 10.1002/iid3.70155.
9
Farnesoid X receptor (FXR) as a potential therapeutic target for lung diseases: a narrative review.法尼酯X受体(FXR)作为肺部疾病的潜在治疗靶点:一篇叙述性综述
J Thorac Dis. 2024 Nov 30;16(11):8026-8038. doi: 10.21037/jtd-24-734. Epub 2024 Nov 29.
10
Silybin Meglumine Mitigates CCl-Induced Liver Fibrosis and Bile Acid Metabolism Alterations.水飞蓟宾葡甲胺减轻四氯化碳诱导的肝纤维化和胆汁酸代谢改变。
Metabolites. 2024 Oct 17;14(10):556. doi: 10.3390/metabo14100556.